Overview
William (Bill) Gaede is known as one of the foremost intellectual property litigators for the life sciences and medical device industries. He serves as lead counsel for a wide range of companies and research institutes and has extensive experience in litigating life science technologies such as antibodies, proteins, small molecules, and diagnostics.
In addition to his substantial jury trial experience, Bill has argued before the US Court of Appeals for the Federal Circuit. He further provides risk management guidance on freedom to operate issues.
Before entering the private sector, Bill served as the temporary deputy district attorney for the City and County of San Francisco.
Results
- Defeated Sanofi’s and Regeneron’s efforts to declare Amgen’s patents, covering a new class of cholesterol lowering anti-PCSK9 antibodies, invalid in this closely watched competitor case; secured a sweeping jury verdict after a one-week jury trial (Amgen Inc. v. Sanofi, Regeneron Pharmaceuticals, et al.)
- Represented Depomed in protecting its flagship pharmaceutical product Gralise® in Hatch-Waxman litigation initiated by six generic drug companies, five of which withdrew their attempt to market a generic drug of Gralise® or settled on terms that secured the market until January 1, 2024; Depomed and remaining entity, Actavis, went to trial, where a sweeping victory was secured for Depomed, finding infringement on all patents and upholding the validity on all asserted patents (Depomed v. Actavis, et al.)
- Defeated Myriad’s 15-year patent-protected monopoly on BRCA gene testing, a process that assesses a woman’s risk of developing breast or ovarian cancer, after successfully defending Ambry Genetics against a 16-patent suit and a preliminary injunction on six of those patents to stop Ambry; resulted in Federal Circuit opinion in In Re Brca1- and Brca2-Based Hereditary Cancer Test Patent Litigation(University of Utah Research Foundation, Myriad Genetics v. Ambry Genetics Corporation)
- Enforced Tercica’s licensed patents against Insmed, relating to new IGF-1 products; after a three-week jury trial, secured a verdict in favor of Tercica on all asserted patents (Tercica, Inc. and Genentech, Inc. v. Insmed)
- Enforced Amgen, Inc.’s patents against F. Hoffman-La Roche, arising out of a pegylated erythropoietin product; after a six-week jury trial, secured a verdict in favor of Amgen on all asserted patents (Amgen v. F. Hoffman-La Roche et al.)
Recognitions
- Legal 500 US, 2021-2024
- Daily Journal, Top Intellectual Property Lawyer, 2016, 2024
- Intellectual Asset Management (IAM) Strategy 300, Global Leaders Guide, 2025
- LMG Life Sciences, General Patent Litigator of the Year – California, 2023
- LMG Life Sciences, Leading Life Sciences Lawyer, 2021-2022
- IAM Patent 1000 – The World’s Leading Patent Practitioners, 2013-2024
- Best Lawyers in America, Biotechnology and Life Sciences,2007-2025; Litigation – Intellectual Property, 2011-2025; Litigation – Patent, 2011-2025; Patent Law, 2011-2025
- Best Lawyers in America, Biotechnology Law “Lawyer of the Year,” 2017 and 2024; Patent Law “Lawyer of the Year,” 2019
- Super Lawyers, Northern California, 2021
- Daily Journal, including 2015 Top 75 Intellectual Property Litigators, 2011 Top 25 Biotech Lawyers in California, and 2009 Top 50 Intellectual Property Litigators
- Chambers USA, 2015
- Who’s Who Legal: Life Sciences, 2021
- Who’s Who Legal Global Leader, Life Sciences – Patent Litigation and Patents, 2019
- Law360 2014, MVP of the Year in Intellectual Property Law for representation of Ambry Genetics, which significantly expanded the market for hereditary breast and ovarian cancer testing
- LMG Life Sciences, Life Science Star, 2012-present
- Managing Intellectual Property, IP Stars, 2013-2024
- The Am Law Litigation Daily, Litigators of the Week, 2017
Community
- Association of Business Trial Lawyers
- San Francisco Bar Association
Credentials
Education
University of California – Hastings College of Law, JD, cum laude, 1988
Pitzer College, BA, 1985
Admissions
California
Courts / Agencies
US Court of Appeals for the Federal Circuit
US Court of Appeals for the Ninth Circuit
US District Court for the Northern District of California
US District Court for the Southern District of California
US District Court for the Eastern District of California
US District Court for the Central District of California
US District Court for the Eastern District of Michigan
